Carole Oskeritzian to Recombinant Proteins
This is a "connection" page, showing publications Carole Oskeritzian has written about Recombinant Proteins.
Connection Strength
0.424
-
Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis. J Immunol. 2004 Jan 01; 172(1):593-600.
Score: 0.189
-
Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol. 1999 Nov 01; 163(9):5105-15.
Score: 0.142
-
Recombinant human (rh) stem cell factor and rhIL-4 stimulate differentiation and proliferation of CD3+ cells from umbilical cord blood and CD3+ cells enhance FcepsilonR1 expression on fetal liver-derived mast cells in the presence of rhIL-4. Cell Immunol. 2003 Nov; 226(1):30-6.
Score: 0.047
-
Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity. J Leukoc Biol. 2016 12; 100(6):1395-1404.
Score: 0.028
-
IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin Exp Allergy. 2001 Jul; 31(7):1077-85.
Score: 0.010
-
Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol. 1996 Oct; 26(10):2517-28.
Score: 0.007